What You Should Know:
- Prescryptive Health, a leading healthcare technology company, today announced the National Community Pharmacists Association's (NCPA) renewed endorsement of Prescryptive AI Pricing.
- Prescryptive AI Pricing creates a dynamic and competitive cash pricing system, enabling independent pharmacies to thrive in the ever-evolving healthcare landscape. This AI-powered solution empowers independent pharmacies to optimize cash pricing and enhance their competitive
Read More
Pharmacy | Medication Adherence Technology Services and Solutions | News, Analysis, Insights - HIT Consultant
Walgreens Launches Specialty Pharmacy for Complex Conditions
What You Should Know:
- Walgreens, a leading pharmacy chain, is making a significant push into the specialty pharmacy market with the launch of "Walgreens Specialty Pharmacy."
- The new $25B initiative expands access to care for patients with complex, chronic conditions while driving profitability for the company.
Walgreens Specialty Pharmacy: A Holistic Approach
Walgreens Specialty Pharmacy aims to break down barriers within the healthcare system. By leveraging
Read More
Lilly Partners with Amazon Pharmacy to Deliver GLP-1 Medications Directly to Patients
What You Should Know:
- Eli Lilly and Company (Lilly) and Amazon Pharmacy today announced a strategic collaboration to improve patient access to GLP-1 medications for diabetes, obesity, and migraines.
- The partnership aims to improve access to these treatments and empower patients with the support they need to manage their chronic conditions.
Addressing a Growing Need
Millions of Americans struggle with diabetes, obesity, and related conditions. Nearly one in three adults
Read More
Waltz Health Enters Medicare Market to Deliver Prescription Drug Savings
What You Should Know:
Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications, today announced its entry into the Medicare market.The company will offer health plans that support Medicare beneficiaries customizable configurations of its proprietary Marketplace Search technology, which lowers prescription drug prices for members and improves their experience, while also providing health plans with critical insight
Read More
How Clinicians Navigate Drug-Drug Interactions to Protect Patients
What You Should Know:
- Drug-drug interactions, a silent threat lurking in medication charts, can cause significant harm and even death. Yet, despite their prevalence, little is known about how doctors identify and manage these risks in real-time.
- A recent groundbreaking study sheds light on this crucial yet under-examined process, offering valuable insights to improve patient safety.
Unveiling the Decision-Making Maze
Led by Dr. Michael Weiner and Dr. Alissa Russ-Jara, the
Read More
Expion Health and Cost Plus Drugs Partner to Combat Soaring Specialty Drug Costs
Prescribing Trends Surge: Wegovy & Ozempic Gain Popularity, Survey Shows
What You Should Know:
- Prescriptions for the popular weight loss drug Wegovy showed a six-fold increase between December 2022 and June 2023, according to a recent analysis of prescribing trends by DrFirst.
- Prescriptions for Ozempic, the lower-dose version for treating diabetes, increased by 65% during the same period among doctors on the DrFirst prescribing network.
- DrFirst's network includes over 350,000 prescribers across the U.S., including 260,000 doctors, who use their
Read More
Q/A: DocStation CEO Shares How AI Will Help Pharmacies Use the DIR Fee Changes to Their Advantage
Early next year, the Centers for Medicare and Medicaid Services (CMS) will remove the application of retroactive DIR fees and move DIR fees to the point of sale instead. The major issues with the DIR fees, which are paid by pharmacies to pharmacy benefit managers, are the fact that they drive up the costs of prescriptions for patients and delay reimbursement of care to the pharmacies.
Now, a brand new issue will arise in early 2024 - namely, pharmacies will be facing a DIR “cliff” where
Read More
High Drug Costs Threatening Affordability of Employer-Sponsored Healthcare
Large employers report that the biggest threat to self-funding medical coverage is the increasingly high cost of pharmacy claims. In their annual Health Benefits Priorities survey, MBGH found that employers consider pharmacy costs extremely problematic. Ninety-one percent of employers cited million-dollar treatments approved by the FDA, and 89% pointed to specialty drug spending as a top threat.
Source: PSG 2023 Trends in Specialty Drug Benefits Report
Employers already pay
Read More
Report: Inaccurate Drug Discount Requests Reach Nearly $1B
What You Should Know:
Kalderos, a data infrastructure and analytics company, identified nearly $1B in inaccurate drug discount requests from 2016-Q1 2023 on its drug discount management platform.The report, titled "Mission Critical: Bringing drug discount stakeholders together so patients win," outlines Kalderos' vision for a new paradigm of cooperation among drug discount program stakeholders in which everyone benefits — particularly patients.
Rising Costs of Inaccurate Drug
Read More
